HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Complete list of metadata

https://hal.univ-brest.fr/hal-02050833
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Wednesday, February 27, 2019 - 1:58:40 PM
Last modification on : Thursday, March 31, 2022 - 11:00:02 AM

Links full text

Identifiers

Citation

Delphine Rea, Franck Nicolini, Michel Tulliez, François Guilhot, Joëlle Guilhot, et al.. Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study. Blood, American Society of Hematology, 2017, 129 (7), pp.846-854. ⟨10.1182/blood-2016-09-742205⟩. ⟨hal-02050833⟩

Share

Metrics

Record views

102